MedTrace Logo

A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic

NCT04375501 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 442

Last updated 2020-05-20

No results posted yet for this study

Summary

In early 2020 the evolving COVID-19 Pandemic provided the world and medical community with a generational challenge. As a novel disease, countries were left with strategic decisions and many went into social lockdown. Initial resources and research were directed at upscaling internal medicine and intensive care services, understanding the disease pathophysiology, and testing treatments. It soon became evident that COVID-19 had multi-system effects at it's worst. In orthopaedics one of the most vulnerable groups to COVID-19 were the elderly, specifically those who suffered fractured neck of femur at this time. More literature is needed urgently if we are to understand and mitigate the negative impacts in this group of patients. This observational study assesses the early morbidity and mortality of patients with this diagnosis during the evolving COVID-19 Pandemic.

Conditions

  • Femoral Neck Fractures
  • SARS-CoV 2

Interventions

OTHER

Surgery: Dynamic Hip Screw, hemiarthroplasty, hip replacement, intramedullary nail

If fit for anaesthesia patients may undergo relevant procedure for fractured neck of femur as per NICE guidelines within limitations of resources as defined by BOAST

Sponsors & Collaborators

  • University College London Hospitals

    collaborator OTHER

  • Barking, Havering and Redbridge University Hospitals NHS Trust

    collaborator OTHER

  • Mid and South Essex NHS Foundation Trust

    collaborator OTHER

  • Frimley Park Hospital NHS Trust

    collaborator OTHER

  • The Hillingdon Hospitals NHS Foundation Trust

    collaborator OTHER_GOV

  • Barts & The London NHS Trust

    lead OTHER

Principal Investigators

  • Babar Kayani, MBBS · Barts & The London NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2020-04-15
Completion
2020-04-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04375501 on ClinicalTrials.gov